Iron Bisglycinate vs Ferrous Sulfate: Gentler, or Just Pricier?

Ask about iron supplements and someone will tell you to skip ferrous sulfate, the cheap pharmacy standby, and buy iron bisglycinate instead, because it is "gentler" and "better absorbed." Bisglycinate costs several times as much per milligram of iron, so it is worth asking what that premium buys. The short answer: some of its reputation holds up, and a surprising amount of it rests on trials that gave the bisglycinate group less iron, on absorption studies done in fortified porridge and bread, and on a meta-analysis that includes two trials retracted this year.

This guide walks through what the head-to-head trials found, what happens when the doses are matched, where the absorption claims come from, what guidelines say, and how the two compare on cost.

The two forms in a nutshell

Both are ferrous iron, the form the gut absorbs most readily. Ferrous sulfate is a simple iron salt and has been the reference form for decades; most of the trials behind oral iron used it. Ferrous bisglycinate is iron bound to two molecules of the amino acid glycine, a structure chemists call a chelate. The best-known branded version is Ferrochel, which appears in many bisglycinate products.

By weight they carry about the same share of iron. NIH's Office of Dietary Supplements lists ferrous sulfate at 20 percent elemental iron, and bisglycinate labels work out to 20 percent too (for example, 36 mg of iron from 180 mg of ferrous bisglycinate). What differs is the dose per pill. A standard 325 mg ferrous sulfate tablet supplies 65 mg of iron, while most bisglycinate capsules supply 18 to 36 mg. That difference in dose turns out to matter for nearly every comparison below.

One regulatory quirk: ferrous sulfate 325 mg is sold both as a dietary supplement and as an over-the-counter drug, depending on the company. Of 30 single-ingredient listings we checked in the National Library of Medicine's DailyMed database, 20 carried Supplement Facts panels and 10 were labeled as OTC drugs. Either way, the tablet is the same compound.

Other common forms carry different amounts of iron: NIH lists ferrous fumarate at 33 percent elemental iron and ferrous gluconate at 12 percent, and the British guideline treats fumarate and gluconate as equal first choices alongside sulfate. Slow-release iron, heme iron and polysaccharide-iron complexes are also sold as gentler options; this guide does not review them, and the same rule applies: compare the elemental iron on the label.

The evidence at a glance

These summaries describe research. They are not claims about what a supplement does. The adult upper limit for iron is 45 mg a day unless a clinician prescribes more, and iron should be taken only when a blood test shows a need or a clinician advises it.

Is bisglycinate gentler on the stomach?

Ferrous sulfate's reputation for upsetting the stomach is earned. A 2015 meta-analysis of 20 placebo-controlled trials found it more than doubled the odds of digestive side effects (odds ratio 2.32), and NIH notes that iron doses of 45 mg a day or more may cause nausea and constipation. So the question is not whether sulfate causes complaints, but whether bisglycinate causes fewer at the same amount of iron.

When the doses were not matched, bisglycinate looked much better. In a Thai pregnancy trial, 7 percent of women taking 24 mg of iron as bisglycinate (with folinic acid and vitamins) reported constipation, against 68 percent of those taking 66 mg as ferrous fumarate; for nausea the figures were 7 and 47 percent. But the trial was not blinded, the bisglycinate group got less than half the iron, and the paper lists funding from Max Biocare, the company that makes the bisglycinate product tested. In a Danish trial, 25 mg of iron as bisglycinate caused fewer digestive complaints overall than 50 mg as ferrous sulfate. A 2024 reanalysis of that trial by the same lead author found no significant difference at any single pregnancy visit, and the bisglycinate group already reported fewer complaints before anyone took iron (24.0 vs 27.5 percent of interview answers). In the reanalysis, the only significant difference came from pooling complaints across visits. According to the 2024 paper, the Danish trial was supported in part by Pharmovital, the company that sells the bisglycinate product it used.

When the doses were matched, the difference mostly disappeared. We found three trials indexed in PubMed that gave both forms at the same iron dose and reported side effects:

• A 1991 double-blind crossover trial in 38 women gave 50 mg of iron as each form for two weeks. The incidence and severity of side effects were not statistically different. Fourteen women had moderate to severe side effects only on sulfate and 8 only on the chelate, and significantly more women preferred the chelate.
• A 2014 double-blind trial in 200 Mexican schoolchildren gave 30 mg of iron a day as either form. About 10 percent had a side effect, with no significant difference between groups.
• A 2013 trial in 56 Colombian preschoolers gave 12.5 mg of iron in fortified milk. Adverse reactions were 43 percent with the chelate and 36 percent with sulfate, a difference that was not significant.

The 2023 meta-analysis also describes a 1994 trial in teenagers that has no PubMed record, in which 120 mg of sulfate caused gastric complaints twice as often as 120 mg of bisglycinate (33.3 vs 15.4 percent, in groups of about 26, with no statistical test reported); the reviewers rated it at high risk of bias. That is the clearest matched-dose signal in bisglycinate's favor, and it is small and old.

Is it simply the lower dose, then? Not proven either. The 2015 sulfate meta-analysis found no clear link between dose and side effects across trials, and in a Danish dose study, digestive complaints did not rise between 20 and 60 mg of iron a day as fumarate, though 80 mg brought more constipation. NIH's own wording is cautious: amino acid chelates "might have fewer gastrointestinal side effects" than iron salts. The fair summary is that lower doses and bisglycinate travel together in most trials, and the data cannot fully separate them. Plenty of people do find bisglycinate easier to take, and if that keeps them taking their iron, that matters.

The meta-analysis everyone cites

Most "bisglycinate is better" articles lean on a 2023 meta-analysis in Nutrition Reviews of 17 randomized trials. In pregnant women it reported higher hemoglobin with bisglycinate (by 0.54 standard deviations, a statistical measure of effect size) and about 64 percent fewer digestive side effects (incidence rate ratio 0.36). In children it found no significant difference in hemoglobin or ferritin. Three details rarely make it into the summaries:

• The certainty was rated very low. The authors rated the overall certainty of the evidence for hemoglobin and ferritin as very low. When they set aside the trials at high or unclear risk of bias, the pregnancy hemoglobin advantage was no longer statistically significant, and two of the four trials left in that analysis are the two later retracted (see below). The side-effect results also varied widely from trial to trial.
• The doses were mostly unequal. In 8 of the 9 pregnancy trials, bisglycinate was given at 15 to 30 mg of iron per dose, against mostly 40 to 115 mg per dose of the comparison iron (in some trials taken two or three times a day). The only matched-dose pregnancy trial is in a journal not indexed in PubMed, and it does not appear to be among the seven trials in the side-effect analysis. The children's trials, which used equal doses, found no significant pooled difference, although two equal-dose trials (in Colombian preschoolers, and in Mexican schoolchildren 6 months after supplements stopped) found higher ferritin with bisglycinate.
• Two of the trials have since been retracted. According to their PubMed records, two Egyptian pregnancy trials included in both the hemoglobin and side-effect analyses (Abdel Moety 2017 and Abbas 2019) were retracted in 2026. We could not read the reasons for either retraction. We found no reanalysis without them, so the meta-analysis's pregnancy figures should be read with that in mind.

None of this shows bisglycinate is worse. It means the strongest numbers quoted for it are weaker than they look.

Is it better absorbed?

The "up to four times better absorbed" line appears to trace back to a 2000 radio-iron study. In 10 men with normal iron stores eating whole-maize porridge, iron from bisglycinate was absorbed at 6.0 percent against 1.7 percent from ferrous sulfate, which the authors called four times higher. A Venezuelan study the same year found bisglycinate absorbed about twice as well as sulfate from fortified bread. Both were testing iron as a food fortificant, where phytates in grains block much of the iron from simple salts. Bisglycinate partly resisted that effect. It did not resist coffee and tea: espresso-type coffee and tea cut its absorption by about half.

Those results are useful for fortifying flour and porridge. They do not show that a bisglycinate capsule taken with water delivers four times as much iron as a sulfate tablet. We found no isotope study comparing the two at equal supplement doses, taken without food, in people with low iron. The supplement-style comparisons we did find showed no clear edge: in water, bisglycinate absorbed about as well as a ferrous ascorbate reference (34.6 vs 29.9 percent, not significantly different); in the second part of the 2000 maize study, at 3 mg of iron in water or porridge, bisglycinate was absorbed less well than a ferrous ascorbate reference (9.1 vs 32.5 percent); and in a small 2025 crossover trial built around a competing iron product, 11 mg of iron as bisglycinate raised blood iron no more than 11 mg as ferrous fumarate.

It does not bypass the body's iron control. Some marketing implies the chelate slips in by a separate route. The same 2000 study concluded that absorption from bisglycinate is "regulated normally by iron status," and a Chilean study found absorption fell as ferritin rose. That is reassuring for safety, but it also means the body absorbs less of any form once stores fill up. A Japanese case report described iron overload in a mother and daughter after long-term use of an over-the-counter chelated iron product, so "gentle" is not the same as "harmless."

Timing is another lever besides form. In iron-depleted women, a 60 mg dose of ferrous sulfate raised hepcidin, a hormone that limits iron absorption, enough to reduce absorption from the next day's dose; taking doses every other day raised the share absorbed. Our guide to taking iron every other day covers those trials.

Can a lower dose do the same job?

The practical promise behind bisglycinate is that a smaller dose can do the work of a larger sulfate dose with fewer side effects. Two trials tested that directly, with different results.

In the Danish pregnancy trial, 80 healthy pregnant women took 25 mg of iron as bisglycinate or 50 mg as ferrous sulfate from mid-pregnancy to delivery. Iron deficiency and anemia were uncommon in both groups and not significantly different, so in these women the lower bisglycinate dose kept pace with the higher sulfate dose.

The larger test went the other way. In a double-blind trial of 480 nonpregnant Cambodian women, most of whom were not iron deficient at the start (6 percent were), 18 mg of iron as bisglycinate failed to show it was as good as 60 mg of ferrous sulfate for raising iron stores. After 12 weeks, ferritin averaged 84 µg/L on bisglycinate, 99 µg/L on sulfate and 78 µg/L on placebo. A marker of gut inflammation (fecal calprotectin) did not differ between groups. The trial was funded by the Canadian Institutes of Health Research; in a 2025 paper from the same trial, the senior author declared grants from Balchem, which owns the Ferrochel brand.

Bisglycinate does raise iron levels compared with placebo. In a 2025 double-blind trial of 830 Dutch blood donors with low ferritin, 10 percent of those taking 30 mg of iron a day as bisglycinate still met the trial's definition of iron deficiency at 56 days, against 51 percent on placebo. The open question is not whether it raises iron levels but whether it beats a salt at the same dose, and whether a much lower dose is enough. A small 2008 trial in 18 people who had stomach surgery found 80 mg of iron as sulfate gave better results than 50 mg as bisglycinate.

What guidelines say

Major guidelines treat the cheap salts as the starting point. A 2024 American Gastroenterological Association expert review states that "no single formulation of oral iron has any advantages over any other" and prefers ferrous sulfate as the least expensive. It also advises giving oral iron once a day at most and notes that every-other-day dosing may be better tolerated.

The British Society of Gastroenterology's 2021 guideline recommends starting with one tablet a day of ferrous sulfate, fumarate or gluconate. If that is not tolerated, its options are a lower dose such as one tablet every other day, an alternative oral preparation, or iron by infusion. It also notes that switching from one traditional iron salt to another is not supported by evidence.

Neither document names bisglycinate as a preferred first choice. Neither rules it out as an alternative for people who cannot tolerate the standard salts.

Label math and cost

Supplement Facts panels list elemental iron, so that is the number to compare. Here is what the products we priced cost on October 31, 2026, at US retail. Prices change and some listings come from third-party sellers.

Prices from retailer and brand listings, read October 31, 2026. Price per 25 mg of iron is our arithmetic. Compare iron amounts, not tablet weights.

Per milligram of iron, the bisglycinate products we priced cost about 4 to 18 times as much as Nature Made ferrous sulfate, and about 2.5 to 10 times as much as Major FeroSul. At the doses people actually take, the gap is smaller but still real: one Thorne capsule a day is about $0.27, against about $0.04 for one ferrous sulfate tablet with more than twice the iron. Over a three-month course, that is roughly $24 against $3.50. The cheapest bisglycinate we priced, Nutricost, works out to about $0.07 a capsule, or about $6 over three months.

Which one should you choose?

Start with why you are taking iron. If a blood test shows low iron and a clinician has suggested a dose, follow that plan; the right amount depends on how low you are.

Ferrous sulfate makes sense if you want the form most trials and guidelines are built on, you are correcting low iron confirmed by a test, and you tolerate it. It is the cheapest way to get a given amount of iron.

Bisglycinate is a reasonable choice if standard iron has upset your stomach and you would rather pay more than stop taking it, or if a lower daily dose suits your needs. In the one blinded crossover trial, more women preferred it, and a supplement you keep taking beats one you quit.

Before switching forms, consider changing the dose or schedule. Taking iron every other day or taking a smaller dose are the first steps guidelines suggest when iron is hard to tolerate. NIH notes that taking iron with food can reduce side effects, but food can cut absorption a lot (by up to 75 percent, says the British guideline, which advises taking iron on an empty stomach or between meals).

Some situations call for a clinician's choice. People with inflammatory bowel disease, those who have had stomach or weight-loss surgery, and people taking acid-reducing medicines may absorb oral iron poorly. In a small 2006 study, people with Crohn's disease absorbed bisglycinate less well than another iron compound (ferrous calcium citrate), and we found no studies of bisglycinate after weight-loss surgery or with acid reducers. Pregnant women should take the iron their midwife or doctor recommends.

Whichever form you pick, keep coffee and tea away from your iron dose, and take calcium supplements at a different time (our calcium guide covers calcium forms). Guidelines disagree on vitamin C. The 2024 AGA review advises adding it to improve absorption, while the British guideline does not recommend it, citing an open-label trial of 440 adults with low iron in which adding 200 mg of vitamin C to each iron dose did not meaningfully change the rise in hemoglobin over two weeks. For product picks, see our iron supplement rankings.

Safety and medicines

Frequently asked questions

Is iron bisglycinate better than ferrous sulfate?

Not clearly, at the same dose. Bisglycinate caused fewer stomach complaints in trials where it was given at a lower dose, but in the few trials that matched doses, side effects mostly did not differ significantly. The 2023 meta-analysis that found higher hemoglobin in pregnancy rated its evidence very low certainty, and two of its trials were retracted in 2026. Guidelines start with ferrous sulfate because it is cheap and well studied.

Is iron bisglycinate easier on the stomach?

Many people find it easier to take, and NIH says amino acid chelates might cause fewer digestive side effects than iron salts. Most trials showing fewer complaints gave less iron as bisglycinate, though. In a 38-woman crossover trial at 50 mg of iron each, side effects were not statistically different, although more women preferred the chelate.

Is iron bisglycinate absorbed better?

In fortified foods, yes: it was absorbed about four times as well as ferrous sulfate from maize porridge and about twice as well from bread. We found no isotope absorption study comparing equal supplement doses in people with low iron, and two small supplement-style studies found no clear advantage. Its absorption is still regulated by the body's iron stores, and in one study espresso-type coffee and tea cut it by about half.

How much iron is in 325 mg of ferrous sulfate?

About 65 mg of elemental iron, because ferrous sulfate is 20 percent iron by weight. Ferrous bisglycinate is also about 20 percent iron, so 125 mg of the compound supplies about 25 mg of iron. Supplement Facts panels list the elemental iron, which is the number to compare.

Can a lower dose of bisglycinate replace a regular iron tablet?

Sometimes, but not reliably. In a Danish pregnancy trial, iron deficiency was similarly uncommon in healthy women taking 25 mg of iron as bisglycinate and those taking 50 mg as ferrous sulfate. In a larger trial of 480 Cambodian women, 18 mg as bisglycinate raised ferritin less than 60 mg as ferrous sulfate. If you are correcting low iron, follow the dose your clinician suggests and recheck your levels.

What can you do if iron upsets your stomach?

Guidelines suggest trying a lower dose or taking iron every other day, and NIH notes that taking it with food can reduce side effects, though food can cut absorption substantially. Switching to bisglycinate is another reasonable option. If iron still causes problems, ask your clinician about other choices, including iron by infusion.

Who should not take iron supplements?

People with hereditary hemochromatosis or other iron-overload conditions should not take iron supplements, and nobody needs extra iron when a blood test shows normal stores. Pregnant women should take the iron their doctor or midwife recommends. Do not give iron to children unless their doctor advises it, and keep all iron products out of their reach, because accidental overdose is a leading cause of fatal poisoning in children under 6. Iron should be taken apart from levothyroxine, some antibiotics and levodopa, so ask your pharmacist how to space doses.

The bottom line

Iron bisglycinate is a fine form of iron, and many people find it easier to take. What the evidence does not show is that it is reliably gentler or better absorbed than ferrous sulfate at the same dose. Most of its advantage in trials came with a lower dose; the absorption multipliers come from fortified foods; and the meta-analysis behind the biggest claims has very low certainty and includes two retracted trials. A lower dose did not keep up with standard sulfate for raising iron stores in the largest double-blind head-to-head trial.

So start with whichever form fits your budget and your stomach. Ferrous sulfate is the cheap, well-studied default that guidelines recommend first. If it bothers you, try a smaller dose or every-other-day dosing, or switch to bisglycinate if you are happy to pay more. Either way, take iron because a test shows you need it, recheck your levels, and keep every iron product out of children's reach.